Skip to main content
JAMA Network logoLink to JAMA Network
. 2018 Jun 20;3(6):505. doi: 10.1001/jamacardio.2018.1224

Error in Figure Data

PMCID: PMC8177368  PMID: 29926100

In the Original Investigation titled “Long-term Thromboembolic Risk in Patients with Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients with Nonvalvular Atrial Fibrillation,”1 published online on March 28, 2018, there were errors in the hazard ratios and 95% CIs presented in Figure 3. The correct values for the odds of a thromboembolic event after oral anticoagulant therapy for patients with nonvalvular atrial fibrillation were 0.59 (95% CI, 0.51-0.68), for the odds of death after oral anticoagulant therapy for patients with postoperative atrial fibrillation, 1.09 (95% CI, 0.82-1.43), and for patients with nonvalvular atrial fibrillation, 0.51 (95% CI, 0.47-0.55).

References

  • 1.Butt JH, Xian Y, Peterson ED, et al. Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation. [published online March 28, 2018]. JAMA Cardiol. doi: 10.1001/jamacardio.2018.0405 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Cardiology are provided here courtesy of American Medical Association

RESOURCES